Literature DB >> 22737616

CD8(+) T lymphocytes infiltrating breast cancer: A promising new prognostic marker?

Sahar Mahmoud1, Andrew Lee, Ian Ellis, Andrew Green.   

Abstract

Lymphocytic infiltration is often seen in breast cancer and has been suggested as a marker of host anti-tumor response but its importance in prognosis remains controversial. Our recent study demonstrated an association between tumor-infiltrating CD8(+) T lymphocytes in invasive breast cancer and better prognosis.

Entities:  

Year:  2012        PMID： 22737616      PMCID： PMC3382867          DOI： 10.4161/onci.18614

Source DB:  PubMed          Journal:  Oncoimmunology        ISSN： 2162-4011            Impact factor:   8.110


  9 in total

1.  Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer.

Authors:  Eiichi Sato; Sara H Olson; Jiyoung Ahn; Brian Bundy; Hiroyoshi Nishikawa; Feng Qian; Achim A Jungbluth; Denise Frosina; Sacha Gnjatic; Christine Ambrosone; James Kepner; Tosin Odunsi; Gerd Ritter; Shashikant Lele; Yao-Tseng Chen; Haruo Ohtani; Lloyd J Old; Kunle Odunsi
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 2.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

3.  Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.

Authors:  Sahar M A Mahmoud; Emma Claire Paish; Desmond G Powe; R Douglas Macmillan; Matthew J Grainge; Andrew H S Lee; Ian O Ellis; Andrew R Green
Journal:  J Clin Oncol       Date:  2011-04-11       Impact factor: 44.544

4.  Prognostic significance of CD8+ T lymphocytes in breast cancer depends upon both oestrogen receptor status and histological grade.

Authors:  Kristi Baker; Jonathan Lachapelle; Inti Zlobec; Tarek A Bismar; Luigi Terracciano; William D Foulkes
Journal:  Histopathology       Date:  2011-06-24       Impact factor: 5.087

5.  Type, density, and location of immune cells within human colorectal tumors predict clinical outcome.

Authors:  Jérôme Galon; Anne Costes; Fatima Sanchez-Cabo; Amos Kirilovsky; Bernhard Mlecnik; Christine Lagorce-Pagès; Marie Tosolini; Matthieu Camus; Anne Berger; Philippe Wind; Franck Zinzindohoué; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Franck Pagès
Journal:  Science       Date:  2006-09-29       Impact factor: 47.728

Review 6.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  The prognostic significance of B lymphocytes in invasive carcinoma of the breast.

Authors:  S M A Mahmoud; A H S Lee; E C Paish; R D Macmillan; I O Ellis; A R Green
Journal:  Breast Cancer Res Treat       Date:  2011-06-14       Impact factor: 4.872

8.  T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

Authors:  Achim Rody; Uwe Holtrich; Laos Pusztai; Cornelia Liedtke; Regine Gaetje; Eugen Ruckhaeberle; Christine Solbach; Lars Hanker; Andre Ahr; Dirk Metzler; Knut Engels; Thomas Karn; Manfred Kaufmann
Journal:  Breast Cancer Res       Date:  2009-03-09       Impact factor: 6.466

9.  An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.

Authors:  Andrew E Teschendorff; Ahmad Miremadi; Sarah E Pinder; Ian O Ellis; Carlos Caldas
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583
  9 in total
  16 in total

Review 1.  A Phenomic Perspective on Factors Influencing Breast Cancer Treatment: Integrating Aging and Lifestyle in Blood and Tissue Biomarker Profiling.

Authors:  Ainhoa Arana Echarri; Mark Beresford; John P Campbell; Robert H Jones; Rachel Butler; Kenneth J Gollob; Patricia C Brum; Dylan Thompson; James E Turner
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

2.  Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.

Authors:  Jie Zhang; Ying Wang; Yang Wu; Zhen-Yu Ding; Xin-Mei Luo; Wu-Ning Zhong; Jie Liu; Xiang-Yu Xia; Guo-Hua Deng; Yao-Tiao Deng; Yu-Quan Wei; Yu Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-14       Impact factor: 4.553

3.  CD4⁺ follicular helper T cell infiltration predicts breast cancer survival.

Authors:  Chunyan Gu-Trantien; Sherene Loi; Soizic Garaud; Carole Equeter; Myriam Libin; Alexandre de Wind; Marie Ravoet; Hélène Le Buanec; Catherine Sibille; Germain Manfouo-Foutsop; Isabelle Veys; Benjamin Haibe-Kains; Sandeep K Singhal; Stefan Michiels; Françoise Rothé; Roberto Salgado; Hugues Duvillier; Michail Ignatiadis; Christine Desmedt; Dominique Bron; Denis Larsimont; Martine Piccart; Christos Sotiriou; Karen Willard-Gallo
Journal:  J Clin Invest       Date:  2013-06-17       Impact factor: 14.808

4.  Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.

Authors:  Shiguang Zhu; Jun Lin; Guangdong Qiao; Yanping Xu; Haidong Zou
Journal:  Tumour Biol       Date:  2015-05-08

5.  Tumor-Associated Stromal Cellular Density as a Predictor of Recurrence and Mortality in Breast Cancer: Results from Ethnically Diverse Study Populations.

Authors:  Montserrat Garcia-Closas; Xiaohong Rose Yang; Mustapha Abubakar; Jing Zhang; Thomas U Ahearn; Hela Koka; Changyuan Guo; Scott M Lawrence; Karun Mutreja; Jonine D Figueroa; Jianming Ying; Jolanta Lissowska; Ning Lyu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-05-05       Impact factor: 4.090

6.  Immune-related gene signatures predict the outcome of neoadjuvant chemotherapy.

Authors:  Gautier Stoll; David Enot; Bernhard Mlecnik; Jérôme Galon; Laurence Zitvogel; Guido Kroemer
Journal:  Oncoimmunology       Date:  2014-02-27       Impact factor: 8.110

7.  Tertiary lymphoid structures are associated with higher tumor grade in primary operable breast cancer patients.

Authors:  Stine L Figenschau; Silje Fismen; Kristin A Fenton; Christopher Fenton; Elin S Mortensen
Journal:  BMC Cancer       Date:  2015-03-06       Impact factor: 4.430

8.  Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.

Authors:  Mina Okabe; Uhi Toh; Nobutaka Iwakuma; Shuko Saku; Momoko Akashi; Yuko Kimitsuki; Naoko Seki; Akihiko Kawahara; Etsuyo Ogo; Kyogo Itoh; Yoshito Akagi
Journal:  Cancer Sci       Date:  2017-01-21       Impact factor: 6.716

Review 9.  Strategies to overcome trastuzumab resistance in HER2-overexpressing breast cancers: focus on new data from clinical trials.

Authors:  Pernelle Lavaud; Fabrice Andre
Journal:  BMC Med       Date:  2014-08-12       Impact factor: 8.775

10.  Expression of NK Cell Surface Receptors in Breast Cancer Tissue as Predictors of Resistance to Antineoplastic Treatment.

Authors:  Mariel Garcia-Chagollan; Irma Edith Carranza-Torres; Pilar Carranza-Rosales; Nancy Elena Guzmán-Delgado; Humberto Ramírez-Montoya; María Guadalupe Martínez-Silva; Ignacio Mariscal-Ramirez; Carlos Alfredo Barrón-Gallardo; Ana Laura Pereira-Suárez; Adriana Aguilar-Lemarroy; Luis Felipe Jave-Suárez
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.